Sentence examples for eligibility to undergo from inspiring English sources
Assessing patients with neuroendocrine tumours (NETs) for their eligibility to undergo treatment with Y- or Lu-radiolabelled somatostatin analogues.
Clients were then screened for medical eligibility to undergo the procedure, following routine protocol for tubal ligations.
Patients who loose eligibility to undergo major liver resection because distant metastases are found at additional staging remain included in the intention-to-treat analysis, as described above.
This guidance document is aimed at assisting and guiding nuclear medicine specialists in: Assessing patients with neuroendocrine tumours (NETs) for their eligibility to undergo treatment with Y- or Lu-radiolabelled somatostatin analogues.
Some patients lose eligibility to undergo major liver resection before exploratory laparotomy (e.g. distant metastases found at staging laparoscopy, deterioration of the patients' condition, or diagnosis of benign disease precluding the need for surgical therapy).
From January 2003 to March 2004, patients with knee osteoarthritis who were attending the knee clinic at the Department of Orthopedic Surgery, Kyoto University Hospital, were screened for eligibility to undergo total knee arthroplasty.
Of these, about 10% (297) agreed to undergo eligibility screening.
One additional patient, fulfilling eligibility criteria, first accepted to undergo surgical procedure, and then refused after the screening visit.
A questionnaire-based definition of 'current asthma' was used in order to facilitate recruitment and avoid any necessity for participants to undergo eligibility testing (e.g. spirometry).
This is an extremely important report because it sets out the conditions of eligibility for persons entitles to undergo ART treatment.
Patients were eligible to participate if they met protocol eligibility criteria for transplantation and were to undergo a related or unrelated nonmyeloablative allogeneic HCT containing fludarabine, cyclophosphamide and TBI along with cyclosporine and mycophenolate mofetil (MMF) for posttransplant immunosuppression.
